Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Phase Two Ventures is a seed venture capital firm based in San Diego, California, dedicated to investing in early-stage life science startups. Founded with the mission to support diverse science entrepreneurs, the firm emphasizes expertise in multi-omics, bioengineering, synthetic biology, and cell & gene therapies. With a focus on research and development tools and platform technologies, Phase Two Ventures aims to facilitate advancements in basic research, diagnostics, and therapeutics. The firm has raised multiple funds, although specific fund sizes are not disclosed. Its assets under management (AUM) and limited partner (LP) base remain unspecified, but the firm is recognized for its strategic approach to investing in the biotech sector. Phase Two Ventures has built a reputation for its commitment to fostering innovation in life sciences, making it a notable player in the startup funding ecosystem.
Phase Two Ventures specializes in early-stage investments within the life sciences sector, particularly focusing on R&D tools, platform technologies, and computational biology. The firm seeks to back startups that are developing innovative solutions to address critical challenges in research and development, diagnostics, and therapeutics. Their investment thesis highlights the potential of technologies that can drive the next generation of scientific discoveries, particularly in areas such as multi-omics, bioengineering, synthetic biology, and cell & gene therapies. The firm typically invests between $100,000 and $500,000 in each startup, allowing them to support a diverse range of companies at the seed stage. By concentrating on the biotech and healthcare sectors within the United States, Phase Two Ventures aims to leverage its expertise and network to help entrepreneurs navigate the complexities of bringing their innovations to market.
Phase Two Ventures has a portfolio of 10 companies, showcasing its commitment to investing in innovative life science startups. Notable investments include Navega Therapeutics, which is developing an AI-enabled zinc finger platform for gene therapies, and Morphos Bioscience, known for its spatial biology platform. Other significant portfolio companies include Potato, which focuses on developing autonomous agents for scientific methods; Exthymic, which is dedicated to accessible autologous cell therapies; and Rybodyn, which is unlocking the dark proteome for drug discovery. The firm has also achieved notable exits, including Mesa Biotech, a healthcare test company acquired by Thermo Fisher, and Sweetspot Diabetes. These investments reflect Phase Two Ventures' strategic focus on companies that are at the forefront of life science innovation, particularly in diagnostics and therapeutic applications.
To pitch Phase Two Ventures, founders should visit their website at phasetwo.vc. The firm welcomes pitches that detail the technology, market potential, and team background. They prefer direct submissions through their online platform.
Phase Two Ventures primarily invests in the seed stage of startup development. The firm focuses on early-stage life science companies that are developing innovative solutions in biotech and healthcare.
Founders interested in pitching to Phase Two Ventures can submit their proposals through their website at phasetwo.vc. The firm typically prefers to receive pitches that clearly outline the technology, market potential, and team background.
Phase Two Ventures focuses on the biotech and healthcare sectors, specifically targeting early-stage life science startups that are developing R&D tools, platform technologies, and computational biology solutions.
The typical check size for investments made by Phase Two Ventures ranges from $100,000 to $500,000, allowing them to support a variety of early-stage companies.
Phase Two Ventures primarily invests in startups located in the United States, with a strong emphasis on companies based in the San Diego area, which is known for its vibrant biotech ecosystem.
Phase Two Ventures adds value to its portfolio companies by leveraging its expertise in life sciences, providing strategic guidance, and facilitating connections within the biotech ecosystem. The firm supports entrepreneurs in navigating the complexities of R&D and commercialization.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.